FDA Announces Plans to Resume Domestic On-site Inspections
FDA Issues Guidance on Manufacturing Drugs, APIs during COVID-19
Navigating FDA Policies for PPE, and Liability Protections
Going Virtual: Clinical Trials, Telemedicine, Electronic Medical Records, And All That.
FDA Updates Policy to Curb Unreliable COVID-19 Antibody Tests
April 16 Update: Key FDA Actions for COVID-19 Devices and Therapies
Upping Hospitals’ Liability Defenses For COVID Measures
